|
521 |
Benralizumab-Induced Asthma Remission: Impact of Different Tools and Thresholds to Define Good Asthma Control Enthalten in Respiration Bd. 105, 2026, Nr. 1: 12-21. 10 S.
|
|
|
522 |
Modified Glasgow Prognostic Score as a Marker for Predicting Outcomes in Patients with either Bladder or Prostate Cancer: A Systematic Review and Meta-Analysis Enthalten in Oncology Bd. 104, 2026, Nr. 2: 212-225. 14 S.
|
|
|
523 |
Patient-Reported Outcome-Based Symptom Management Improves Quality of Life in Postoperative Gastroesophageal Cancer Patients: A Randomized Controlled Trial Enthalten in Oncology Bd. 104, 2026, Nr. 2: 201-211. 11 S.
|
|
|
524 |
Impact of Social Vulnerability Index on Multiple Myeloma Mortality Enthalten in Oncology Bd. 104, 2026, Nr. 2: 176-180. 5 S.
|
|
|
525 |
Determining the Cut-Off Value of the MASCC Score to Predict Mortality in Hospitalized Febrile Neutropenic Patients: A Decade-Long Single-Center Retrospective Cohort Study Enthalten in Oncology Bd. 104, 2026, Nr. 2: 167-175. 9 S.
|
|
|
526 |
Antihistamines Improve the Survival of Lung Cancer: A 10-Year Cohort Study of Tertiary Hospital in Taiwan Enthalten in Oncology Bd. 104, 2026, Nr. 2: 103-112. 10 S.
|
|
|
527 |
The Current Status of Tumor Markers as Biomarkers in the Era of Immunotherapy for Hepatocellular Carcinoma: Alpha-Fetoprotein Alone Is Not Sufficient Enthalten in Oncology Bd. 104, 2026, Nr. 1: 79-91. 13 S.
|
|
|
528 |
Variations in Characteristics and Clinical Outcomes of Esophageal Squamous Cell Carcinoma among Asian American Enthalten in Oncology Bd. 104, 2026, Nr. 1: 51-62. 12 S.
|
|
|
529 |
ISPAD Position Statement on Type 1 Diabetes in Schools Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 147-157. 11 S.
|
|
|
530 |
Variability in Body Mass Index during 2018–2021 for People with Type 1 Diabetes: Real World Data from the USA, Germany, and Australasia Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 138-146. 9 S.
|
|